Waratah Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,250
Closed -$207K – 252
2021
Q3
$207K Buy
+1,250
New +$215K ﹤0.01% 249
2021
Q2
– Sell
-14,665
Closed -$2.83M – 270
2021
Q1
$2.83M Buy
+14,665
New +$2.82M 0.06% 101
2015
Q4
– Sell
-3,300
Closed -$381K – 183
2015
Q3
$381K Buy
+3,300
New +$370K 0.08% 77
2014
Q3
– Sell
-7,350
Closed -$672K – 45
2014
Q2
$672K Buy
7,350
+4,150
+130% +$372K 0.33% 49
2014
Q1
$282K Sell
3,200
-6,500
-67% -$571K 0.16% 63
2013
Q4
$900K Buy
+9,700
New +$874K 0.35% 63

Other funds holding CLX

Waratah Capital Advisors's CLX Position: Q4 2021 in Review

Waratah Capital Advisors sold out of Clorox (CLX) in Q4 2021, closing a stake of 1,250 shares — an estimated $207K sold.

Waratah Capital Advisors first reported a position in CLX in Q4 2013 and held it in 6 quarters. The position peaked at $2.83M in Q1 2021. 1,220 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

  • Waratah Capital Advisors reported no remaining Clorox position as of Q4 2021 after selling out during the quarter.
  • Waratah Capital Advisors sold 1,250 Clorox shares in Q4 2021, an estimated $207K.
  • Waratah Capital Advisors first reported a position in Clorox in Q4 2013 and held it in 6 quarters.
  • Waratah Capital Advisors's Clorox position peaked at $2.83M in Q1 2021.
  • 1,220 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Waratah Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.